Functional regulation of phospholipase D expression in cancer and inflammation

Area of Science:

• Biochemistry and Molecular Biology
• Cell Signaling
• Pharmacology

Background:

• Phospholipase D (PLD) generates phosphatidic acid, regulating downstream signaling pathways.
• Dysregulation of PLD is increasingly linked to human diseases, including cancer and inflammatory conditions.
• Understanding PLD's regulatory network is crucial for developing targeted therapies.

Purpose of the Study:

• To summarize recent advancements in understanding PLD expression regulation.
• To review the role of PLD in the progression of cancer and inflammatory diseases.
• To highlight the therapeutic potential of small molecule PLD inhibitors.

Main Methods:

• Literature review of scientific developments on PLD regulation and function.
• Analysis of studies investigating PLD's role in pathological conditions.
• Evaluation of research on small molecule PLD inhibitors in disease models.

Main Results:

• Aberrant PLD expression is a feature of various complex diseases.
• Small molecule PLD inhibitors can reduce both PLD expression and enzymatic activity.
• These inhibitors have demonstrated efficacy in preclinical models of cancer and inflammation.

Conclusions:

• PLD is a significant molecular target for therapeutic intervention in cancer and inflammation.
• Small molecule inhibitors represent a promising strategy for managing diseases associated with PLD dysregulation.
• Further research into PLD signaling networks could uncover novel therapeutic avenues.